Categories AlphaGraphs, Earnings, Industrials
A visual representation of Honeywell (HON) Q1 2020 earnings results
Honeywell International Inc. (NYSE: HON) reported its financial results for the quarter ended March 31, 2020 today. The bottom-line came in above the analysts’ expectations while the top line missed consensus estimates.
Honeywell posted a 12% jump in earnings for the first quarter of 2020 helped by lower costs and expenses despite a 5% decline in the top-line. The softness in the building solutions projects and volume declines in security and building management products hurt Honeywell Building Technologies.

The company’s Performance Materials and Technologies and Safety and Productivity Solutions segments showed declines in sales for the quarter. However, the Aerospace segment showed a marginal rise backed by continued strength in the Defense and Space business and growth in air transport commercial aftermarket.
Due to the evolving nature of the COVID-19 pandemic and related supply chain and market disruptions, Honeywell said it has temporarily suspended its full-year guidance until the economic impact of coronavirus stabilizes. The company expects ongoing top-line challenges due to the current market conditions, particularly in the aerospace and oil and gas sectors.
Past Performance
Honeywell Q4 2019 Earnings Results
HON Q3 2019 Earnings Performance
Most Popular
Infographic: Amazon (AMZN) Q4 2024 earnings beat estimates; sales rise 10%
E-commerce giant Amazon.com Inc. (NASDAQ: AMZN) on Thursday reported higher sales and profit for the fourth quarter of 2024. Earnings also beat analysts' estimates. Net sales increased to $187.8 billion
Philip Morris (PM) delivers strong performance in 4Q24 helped by smoke-free strength
Shares of Philip Morris International Inc. (NYSE: PM) jumped 10% on Thursday after the company delivered better-than-expected earnings results for the fourth quarter of 2024 and provided an encouraging outlook
Highlights of Bristol-Myers Squibb’s Q4 2024 earnings report
Biotechnology company Bristol Myers Squibb (NYSE: BMY) reported lower profit for the fourth quarter of 2024, despite an increase in revenue. Net income attributable to shareholders was $72 million or